All News Articles

VIENNA, AUSTRIA, OCTOBER 10, 2010 - GE Healthcare, a unit of General Electric Company (NYSE:GE) and Advanced Cyclotron Systems, Inc. (ACSI), a world leader in the design and manufacturing of cyclotron equipment, announced today their Memorandum of Understanding (MOU) to explore opportunities for collaboration on High Energy (24 and 30 MeV) cyclotrons and related equipment, during this year’s European Association of Nuclear Medicine Congress (EANM) being held in Vienna, Austria. 

ACSI TR19 cyclotron to further Europe's research in nuclear medical radioisotopes

Vancouver, BC Canada – (October 4, 2010) – Advanced Cyclotron Systems Inc. (ACSI) a leading provider of cyclotron solutions, announced that it has sold a TR19 variable energy (14 - 19 MeV) cyclotron to Horia Hulubei National Institute of Physics and Nuclear Engineering (IFIN-HH), Magurele-Ilfov, Romania.

(RICHMOND, B.C.) – A private company is working in partnership with two of Canada's leading nuclear medicine research centres to develop a solution to the medical isotope crisis for wide spread use.

Advanced Cyclotron Systems Inc. (ACSI) a leading manufacturer of cyclotrons for the production of medical radioisotopes announced today that it has sold two TR-24 cyclotrons to the University of Alberta's Department of Oncology in Edmonton and the Centre Hospitalier Universitaire de Sherbrooke (CHUS) in Quebec.

Researchers at the CHUS's Centre de recherche clinique Étienne-Le Bel (CRCELB) and the Université de Sherbrooke, in collaboration with Advanced Cyclotron Systems Inc. in Richmond, have just demonstrated that technetium 99m can be produced using a cyclotron. Diagnostic testing indicates that cyclotron-produced technetium 99m is fully equivalent to that obtained from nuclear reactor, such as the Chalk River facility.